MRK · News · 20260903N
Revenue Performance and Mix
Merck & Co., Inc. · 2026-09-03 · Importance 36 · Surprise 14
Merck reported quarterly revenue of $16.61 billion, representing 5.1% year-over-year growth. Keytruda was identified as a primary growth driver, supported by contributions from newer products. The revenue result exceeded analyst expectations for the quarter.
Key facts
- Merck reported a narrower-than-expected Q2 2026 loss and beat revenue estimates. source